# N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder

> **NCT01172275** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 11 (actual)

## Conditions studied

- Obsessive-Compulsive Disorder

## Interventions

- **DRUG:** N-Acetylcysteine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01172275
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2017-02-13
- **Final completion:** 2018-02-15
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2019-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01172275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01172275, "N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01172275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*